Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1980 Jun 14;280(6229):1401–1403. doi: 10.1136/bmj.280.6229.1401

Cancer in patients receiving dialysis.

L J Kinlen, J B Eastwood, D N Kerr, J F Moorhead, D O Oliver, B H Robinson, H E de Wardener, A J Wing
PMCID: PMC1601729  PMID: 7427132

Abstract

The incidence of cancer and related mortality was studied in 1651 patients from six dialysis centres in England over 10 years. The only type of cancer for which there was a significant excess was non-Hodgkin's lymphoma (four cases observed against an expected incidence of 0.15 (p < 0.001); three deaths against an expected 0.1 (p < 0.001)). This excess could not be attributed to either subsequent transplantation or treatment with immunosuppressive drugs. Since immunodepression is a feature of chronic renal failure, these observations together with those on patints treated with immunosuppressive drugs suggest that immunosuppression favours the development of non-Hodgkin's lymphoma. Studies in which it is concluded that patients receiving dialysis show an excess of other types of cancer have certain shortcomings; the unusual opportunities for detecting cancer in such patients may account for some of the reported excess.

Full text

PDF
1401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bengtsson U., Angervall L., Ekman H., Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol. 1968;2(3):145–150. doi: 10.3109/00365596809135358. [DOI] [PubMed] [Google Scholar]
  2. Bichel J., Jensen K. B. Nephrotic syndrome and Hodgkin's disease. Lancet. 1971 Dec 25;2(7739):1425–1426. doi: 10.1016/s0140-6736(71)90704-5. [DOI] [PubMed] [Google Scholar]
  3. Birkeland S. A. Uremia as a state of immune deficiency. Scand J Immunol. 1976;5(1-2):107–115. doi: 10.1111/j.1365-3083.1976.tb02997.x. [DOI] [PubMed] [Google Scholar]
  4. Couser W., Badger A., Cooperband S., Stilmand M., Jermanovich N., Aurora S., Doner D., Schmitt G. Hodgkin's disease and lipoid nephrosis. Lancet. 1977 Apr 23;1(8017):912–913. doi: 10.1016/s0140-6736(77)91246-6. [DOI] [PubMed] [Google Scholar]
  5. Dunnill M. S., Millard P. R., Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol. 1977 Sep;30(9):868–877. doi: 10.1136/jcp.30.9.868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Froom D. W., Franklin W. A., Hano J. E., Potter E. V. Immune deposits in Hodgkin's disease with nephrotic syndrome. Arch Pathol. 1972 Dec;94(6):547–553. [PubMed] [Google Scholar]
  7. Hansen H. E., Skov P. E., Askjaer S. A., Albertsen K. Hodgkin's disease associated with the nephrotic syndrome without kidney lesion. Acta Med Scand. 1972 Apr;191(4):307–313. [PubMed] [Google Scholar]
  8. Hoover R., Fraumeni J. F., Jr Risk of cancer in renal-transplant recipients. Lancet. 1973 Jul 14;2(7820):55–57. doi: 10.1016/s0140-6736(73)93256-x. [DOI] [PubMed] [Google Scholar]
  9. Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Matas A. J., Simmons R. L., Kjellstrand C. M., Buselmeier T. J., Najarian J. S. Increased incidence of malignancy during chronic renal failure. Lancet. 1975 Apr 19;1(7912):883–886. doi: 10.1016/s0140-6736(75)91684-0. [DOI] [PubMed] [Google Scholar]
  11. Matos A. J., Simmons R. L., Kjellstrand C. M., Buselmeier T. J., Johnson T. L., Najarian J. S. Increased incidence of malignancy in uremic patients and its significance to transplantation. Transplant Proc. 1977 Mar;9(1):1137–1140. [PubMed] [Google Scholar]
  12. Miach P. J., Dawborn J. K., Xipell J. Neoplasia in patients with chronic renal failure on long-term dialysis. Clin Nephrol. 1976 Mar;5(3):101–104. [PubMed] [Google Scholar]
  13. Moorthy A. V., Zimmerman S. W., Burkholder P. M. Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med. 1976 Oct;61(4):471–477. doi: 10.1016/0002-9343(76)90325-9. [DOI] [PubMed] [Google Scholar]
  14. Penn I., Starzl T. E. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation. 1972 Oct;14(4):407–417. doi: 10.1097/00007890-197210000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Routledge R. C., Hann I. M., Jones P. H. Hodgkin's disease complicated by the nephrotic syndrome. Cancer. 1976 Oct;38(4):1735–1740. doi: 10.1002/1097-0142(197610)38:4<1735::aid-cncr2820380447>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  16. Sherman R. L., Susin M., Weksler M. E., Becker E. L. Lipoid nephrosis in Hodgkin's disease. Am J Med. 1972 May;52(5):699–706. doi: 10.1016/0002-9343(72)90060-5. [DOI] [PubMed] [Google Scholar]
  17. Slifkin R. F., Goldberg J., Neff M. S., Baez A., Mattoo N., Gupta S. Malignancy in end-stage renal disease. Trans Am Soc Artif Intern Organs. 1977;23:34–40. doi: 10.1097/00002480-197700230-00010. [DOI] [PubMed] [Google Scholar]
  18. Sutherland G. A., Glass J., Gabriel R. Increased incidence of malignancy in chronic renal failure. Nephron. 1977;18(3):182–184. doi: 10.1159/000180813. [DOI] [PubMed] [Google Scholar]
  19. Tasker P. R., Walden P. A., Gower P. E., Bagshawe K. D. Reticulosarcoma occurring during long-term hemodialysis. Clin Nephrol. 1975 Jan;3(1):28–30. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES